Case Study: Farsight Genome Systems accelerates genomic testing with ClearDATA

ClearDATA Helps Speed to Market Groundbreaking Genomic Testing Solution

Farsight Genome Systems, a precision medicine company based in Sunnyvale, needed a turnkey IT platform to support its genomic testing solution, which stored more than two terabytes of data and included protected health information (PHI). The company also wanted a scalable path to AWS without the time and cost of building an internal dev-ops team, while meeting HIPAA privacy and security requirements. ClearDATA was selected to help address these needs.

ClearDATA built a complete IT platform for Farsight Genome Systems in just weeks on VMware, with a migration to AWS planned. The solution provided a rapidly scalable, HIPAA-compliant environment that turned infrastructure into an operational expense and avoided the capital outlay of hiring internal dev-ops resources. As a result, Farsight Genome was able to speed time to market for its diagnostics platform and launch a solution that helped customers identify previously hidden gene variances linked to treatment options.

Farsight Genome Systems

Glenda Anderson

Chief Executive Officer and Founder